5-Year Prognostic Value of Quantitative Versus Visual MPI in Subtle Perfusion Defects: Results From REFINE SPECT.

OBJECTIVES This study compared the ability of automated myocardial perfusion imaging analysis to predict major adverse cardiac events (MACE) to that of visual analysis. BACKGROUND Quantitative analysis has not been compared with clinical visual analysis in prognostic studies. METHODS A total of 19,495 patients from the multicenter REFINE SPECT (REgistry of Fast Myocardial Perfusion Imaging with NExt generation SPECT) study (64 ± 12 years of age, 56% males) undergoing stress Tc-99m-labeled single-photon emission computed tomography (SPECT) myocardial perfusion imaging were followed for 4.5 ± 1.7 years for MACE. Perfusion abnormalities were assessed visually and categorized as normal, probably normal, equivocal, or abnormal. Stress total perfusion deficit (TPD), quantified automatically, was categorized as TPD = 0%, TPD >0% to <1%, ≤1% to <3%, ≤3% to <5%, ≤5% to ≤10%, or TPD >10%. MACE consisted of death, nonfatal myocardial infarction, unstable angina, or late revascularization (>90 days). Kaplan-Meier and Cox proportional hazards analyses were performed to test the performance of visual and quantitative assessments in predicting MACE. RESULTS During follow-up examinations, 2,760 (14.2%) MACE occurred. MACE rates increased with worsening of visual assessments, that is, the rate for normal MACE was 2.0%, 3.2% for probably normal, 4.2% for equivocal, and 7.4% for abnormal (all p < 0.001). MACE rates increased with increasing stress TPD from 1.3% for the TPD category of 0% to 7.8% for the TPD category of >10% (p < 0.0001). The adjusted hazard ratio (HR) for MACE increased even in equivocal assessment (HR: 1.56; 95% confidence interval [CI]: 1.37 to 1.78) and in the TPD category of ≤3% to <5% (HR: 1.74; 95% CI: 1.41 to 2.14; all p < 0.001). The rate of MACE in patients visually assessed as normal still increased from 1.3% (TPD = 0%) to 3.4% (TPD ≥5%) (p < 0.0001). CONCLUSIONS Quantitative analysis allows precise granular risk stratification in comparison to visual reading, even for cases with normal clinical reading.

[1]  D. Berman,et al.  Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging. , 2014, JACC. Cardiovascular imaging.

[2]  L. Shaw,et al.  Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[4]  Daniel S. Berman,et al.  Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion spect interpretation , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[5]  D. Berman,et al.  Quantitative Upright–Supine High-Speed SPECT Myocardial Perfusion Imaging for Detection of Coronary Artery Disease: Correlation with Invasive Coronary Angiography , 2010, The Journal of Nuclear Medicine.

[6]  Albert Flotats,et al.  Current worldwide nuclear cardiology practices and radiation exposure: results from the 65 country IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS) , 2015, European heart journal.

[7]  D. Berman,et al.  Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. , 1996, Circulation.

[8]  Valerie Treyer,et al.  Nuclear Myocardial Perfusion Imaging with a Cadmium-Zinc-Telluride Detector Technique: Optimized Protocol for Scan Time Reduction , 2010, Journal of Nuclear Medicine.

[9]  D. Berman,et al.  Prognostic Implications of Myocardial Perfusion Single-Photon Emission Computed Tomography in the Elderly , 2009, Circulation.

[10]  Guido Germano,et al.  Fully automated analysis of attenuation-corrected SPECT for the long-term prediction of acute myocardial infarction , 2018, Journal of Nuclear Cardiology.

[11]  Douglas S. Lee,et al.  Cardiovascular outcomes are predicted by exercise-stress myocardial perfusion imaging: Impact on death, myocardial infarction, and coronary revascularization procedures. , 2011, American heart journal.

[12]  J. Ottervanger,et al.  Prognostic Value of Myocardial Perfusion Imaging with a Cadmium-Zinc-Telluride SPECT Camera in Patients Suspected of Having Coronary Artery Disease , 2017, The Journal of Nuclear Medicine.

[13]  Russell D Folks,et al.  The increasing role of quantification in clinical nuclear cardiology: The Emory approach , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[14]  Randall C. Thompson,et al.  Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging Guidelines: Instrumentation, Acquisition, Processing, and Interpretation , 2018, Journal of Nuclear Cardiology.

[15]  D. Berman,et al.  Automated quantification of myocardial perfusion SPECT using simplified normal limits , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[16]  Piotr J. Slomka,et al.  Rationale and design of the REgistry of Fast Myocardial Perfusion Imaging with NExt generation SPECT (REFINE SPECT) , 2018, Journal of Nuclear Cardiology.

[17]  Damini Dey,et al.  Prognostic Value of Combined Clinical and Myocardial Perfusion Imaging Data Using Machine Learning. , 2017, JACC. Cardiovascular imaging.

[18]  D. Berman,et al.  Prognostic value of quantitative high-speed myocardial perfusion imaging , 2012, Journal of Nuclear Cardiology.

[19]  A. Iskandrian,et al.  The prognostic value of regadenoson myocardial perfusion imaging , 2015, Journal of Nuclear Cardiology.

[20]  R. Redberg,et al.  The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. , 2007, Journal of the American College of Cardiology.

[21]  Terrence D. Ruddy,et al.  Optimization of SPECT Measurement of Myocardial Blood Flow with Corrections for Attenuation, Motion, and Blood Binding Compared with PET , 2017, The Journal of Nuclear Medicine.

[22]  J. Piccini,et al.  Single-Photon Emission Computed Tomography Myocardial Perfusion Defects Are Associated With an Increased Risk of All-Cause Death, Cardiovascular Death, and Sudden Cardiac Death , 2008, Circulation. Cardiovascular imaging.

[23]  K. Nakajima,et al.  Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Circulation.

[25]  Jim Patton,et al.  A Novel High-Sensitivity Rapid-Acquisition Single-Photon Cardiac Imaging Camera , 2009, Journal of Nuclear Medicine.

[26]  G. Heller,et al.  Risk stratification using line source attenuation correction with rest/stress Tc-99m sestamibi SPECT myocardial perfusion imaging , 2014, Journal of Nuclear Cardiology.

[27]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.

[28]  W. Leslie,et al.  Prognostic value of automated quantification of 99mTc-sestamibi myocardial perfusion imaging. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  Benjamin C. Lee,et al.  Corridor4DM: The Michigan method for quantitative nuclear cardiology , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.